Join Team DHCS!

DHCS is seeking a mission-driven MD/DO to guide DHCS’ ambitious agenda to ensure high-quality and accessible mental health and substance use disorder services in Medi-Cal and other public programs.

The Medical Consultant II position will provide clinical expertise and strategic advice to DHCS Behavioral Health leadership on the development and implementation of policy and initiatives designed to strengthen behavioral health care access, quality, and service delivery, and achieve equitable health care outcomes for 15 million Medi-Cal members and Californians served through other programs. The position, located within the Medi-Cal Behavioral Health Policy Division, will provide cross-cutting support to all DHCS Behavioral Health teams, and will collaborate across the Department and externally. The Medical Consultant II will shape the implementation of an unprecedented array of behavioral health funding investments, policy changes, and innovative initiatives that DHCS is leading to better meet the needs of the communities we serve. This is an incredible opportunity to support the change management process for a once-in-a-generation moment of behavioral health reform in California.

Full-time telework permitted. Board certifications in psychiatry and addiction medicine or addiction psychiatry preferred. For more information, please visit the Cal Careers website.

Please share with your networks. Thank you!

For any questions, please contact the DHCS Hiring Manager for this position, Jamie Shigetoshi, at Jamie.Shigetoshi@dhcs.ca.gov. Please feel free to cc Ivan Bhardwaj at Ivan.Bhardwaj@dhcs.ca.gov.

Medical Board of California Announcement:

Certain Licensing Documents Must be Submitted Online Starting January 1, 2024

The Direct Online Certification Submission (DOCS) service is a secure, fast, and reliable online document delivery system that allows medical schools and postgraduate training programs to submit certain primary-source licensing documents to the Board.


Effective January 1, 2024, the Board will only accept the following documents through DOCS for an open application, or through any of the other Board-accepted third party services identified on the Board’s website.


• Certificate of Medical Education (Form MED)
• Official Transcript
• Official English Translation of Transcript
• Postgraduate Training License Enrollment Form (Form EF)
• Certificate of Completion of ACGME/RCPSC/CFPC Postgraduate Training (Form PTA-B)
• Certificate of Completion of CODA Postgraduate Training (Form CODA1-CODA2)
• Current Postgraduate Training Verification (Form CTV)
• Explanation to Application Question (Form EXP)


The Board will not accept these documents if submitted by mail, which will delay the processing of the license application. The DOCS registration form is available on the Board’s website. DOCS registration forms and questions about registering may be emailed to docs@mbc.ca.gov.

DEA Hosts Public Listening Sessions on Telemedicine Regulations on September 12-13, 2023

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available.

WHAT: Public Listening Sessions on Telemedicine Regulations
WHO: Open to the public
WHEN: September 12-13, 2023
WHERE: DEA Headquarters, 700 Army Navy Drive, Arlington, Va. 22202

FOR MEMBERS OF THE PUBLIC: Beginning on August 7, members of the public wishing to attend in person (space permitting) must register HERE by August 21, 2023 at 11:59 p.m. DEA is accepting requests to make limited oral presentations during the public meeting. Persons wishing to give an oral presentation – in person or virtually – time permitting, must indicate the desire to present when requesting to register. Presentations will be limited to 10 minutes.

Read More…

U.S. House Vote Tomorrow (May 25): Oppose Harsh Drug Penalties

FROM THE DRUG POLICY ALLIANCE:

The U.S. House will vote on the HALT Fentanyl Act tomorrow. This misguided bill would ramp up harsh mandatory minimum sentences for fentanyl analogues. And it would permanently make all fentanyl-related substances Schedule I without first testing them for benefits or harm. 

Criminalization has failed to keep us safer. Instead, it’s actually fueling the tragic overdose crisis. Increasing penalties will only make things worse. 

Saving lives requires a health approach, not more punishment. This bill is a step in the wrong direction. Help us to oppose it: tell your Representative to vote against the HALT Fentanyl Act right now.

We expect this vote to be close so it’s vital for constituents like you to also make…

Read More…

Nominations Open for the 2023 Vernelle Fox & Community Service Awards!

CSAM is now accepting nomination submissions for the Vernelle Fox & Community Service Awards!

Honoring an Inquiring Mind, Courage, and Enthusiasm

  • Inquiring Mind – Contributions to the understanding of the field
  • Courage – Resolution and tenacity
  • Enthusiasm – Energy for the positive

CSAM recognizes physicians who have made noteworthy and lasting contributions in line with the mission of the Society: contributions which improve the quality of health care services, increase communication and education among providers of care and add to the research on which the understanding of the field is based and on which the health care services are built.

This award will be presented to the selected candidate during the CSAM 2023 Addiction Medicine Review Course and Board Exam Preparation Track.

If you have someone in mind you feel is worthy of the Vernelle Fox Award, please CLICK HERE to submit a nomination on their behalf.

Please submit your nomination by June 15, 2023!


Recognizing non-physicians who make outstanding contributions to the community

The Community Service award recognizes a non-physician who made outstanding contributions to the community. This CSAM award is presented based on merit and since 1985, it has been awarded to a wide variety of legislators, activists, community leaders, etc., all with one thing in common: they have improved the lives of those suffering from the disease of addiction, and by doing so have contributed a valuable service to the community.

This award will be presented to the selected candidate during the CSAM 2023 Addiction Medicine Review Course and Board Exam Preparation Track.

If you have someone in mind you feel is worthy of the Community Service Award, please CLICK HERE to submit a nomination on their behalf.

Please submit your nomination by June 15, 2023!

Governor Newsom Releases Master Plan for Tackling the Fentanyl and Opioid Crisis

Governor Newsom has invested over $1 billion to tackle the crisis
Through CalRx, California will seek to manufacture its own Naloxone
Master Plan provides comprehensive approach to save more lives

SAN DIEGO COUNTY – Today, following a visit to the San Ysidro Port of Entry, Governor Gavin Newsom released his administration’s Master Plan for Tackling the Fentanyl and Opioid Crisis. Recognizing the opioid and fentanyl crisis as a multifaceted public health and public safety issue, Governor Newsom’s Master Plan provides a comprehensive approach to save lives. The Master Plan builds on the Governor’s $1 billion investment to tackle this crisis — including an expansion of California National Guard-supported operations that last year led to a 594% increase in seized fentanyl. The Master Plan outlines aggressive steps to support overdose prevention efforts, hold the opioid pharmaceutical industry accountable, crack down on drug trafficking, and raise awareness about the dangers of opioids, including fentanyl.

WHAT GOVERNOR NEWSOM SAID: “Over 150 people die every day in our nation from overdoses and poisonings related to synthetic opioids like fentanyl. Enough. With this Master Plan, California is doubling down to combat this crisis and save lives. Our comprehensive approach will expand enforcement efforts to crack down on transnational criminal organizations trafficking this poison into our communities — while prioritizing harm reduction strategies to reduce overdoses and compassionately help those struggling with substance use and addiction.”
View the Master Plan

DEA Announces Important Change to Registration Requirement

On December 29, 2022, with the signing of the Consolidated Appropriations Act of 2023 (the Act), Congress eliminated the “DATA-Waiver Program.”

All DEA registrants should be aware of the following:

  • A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder.
  • Going forward, all prescriptions for buprenorphine only require a standard DEA registration number. The previously used DATA-Waiver registration numbers are no longer…